Open-label, uncontrolled, multicenter phase II study to evaluate the efficacy and toxicity of cetuximab as a single agent in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck who failed to respond to platinum-based therapy
収録刊行物
-
- J Clin Oncol
-
J Clin Oncol 25 2152-2155, 2007
- Tweet
詳細情報
-
- CRID
- 1573387450387035136
-
- NII論文ID
- 10021293574
-
- データソース種別
-
- CiNii Articles